ICU Medical(US:ICUI)2021-11-04 17:25Revenue Performance - Infusion Consumables Q3 2021 revenue reached $145 million, showing a year-over-year growth of 25% [8] - IV Solutions Q3 2021 revenue was $81 million, a decrease of 6% compared to the previous year [8] - Infusion Systems Q3 2021 revenue amounted to $91 million, reflecting a 3% increase year-over-year [8] - Critical Care Q3 2021 revenue was $11 million, down 8% from the previous year [8] - Total adjusted revenue for Q3 2021 was $328 million, representing an 8% increase year-over-year [8] Financial Adjustments and Gross Profit - GAAP net sales for the three months ended September 30, 2021, were $336060 thousand [9] - Non-GAAP net sales for the three months ended September 30, 2021, were $328141 thousand [9] - GAAP gross profit for the three months ended September 30, 2021, was $127791 thousand, with a gross profit margin of 38% [9] - Non-GAAP gross profit for the three months ended September 30, 2021, was $132204 thousand, resulting in a gross profit margin of 40% of non-GAAP net sales [9]